Journal article · 2020
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
Cancer Immunology Research, 8(10), 1300–1310 · Published 1 September 2020 · DOI 10.1158/2326-6066.cir-20-0304
In brief
“Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity” is a 2020 journal article by Helen Kotanides and 27 co-authors, published in Cancer Immunology Research. OpenAlex counts 72 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 72
- Most cited in
- 2024 (18)
- Field-weighted impact
- 3.13
- References
- 44
- Authors
- 28
Abstract
The programmed cell death protein 1 receptor (PD-1) and programmed death ligand 1 (PD-L1) coinhibitory pathway suppresses T-cell–mediated immunity. We hypothesized that cotargeting of PD-1 and PD-L1 with a bispecific antibody molecule could provide an alternative therapeutic approach, with enhanced antitumor activity, compared with monospecific PD-1 and PD-L1 antibodies. Here, we describe LY3434172, a bispecific… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Kotanides, H., Li, Y. H., Malabunga, M., Carpenito, C., Eastman, S. W., Shen, Y., Wang, G., Inigo, I. V., Surguladze, D., Pennello, A. L., Persaud, K., Hindi, S., Topper, M. B., Chen, X., Zhang, Y., Bulaon, D. K., Bailey, T., Lao, Y., Han, B., . . . Kalos, M. D. (2020). Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity. Cancer Immunology Research, 8(10), 1300–1310. https://doi.org/10.1158/2326-6066.cir-20-0304
MLA 9
Kotanides, Helen, et al. “Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity.” Cancer Immunology Research, vol. 8, no. 10, 2020, pp. 1300–1310. https://doi.org/10.1158/2326-6066.cir-20-0304.
Chicago
Kotanides, Helen, Yiwen Helen Li, Maria Malabunga, Carmine Carpenito, Scott W. Eastman, Yang Shen, George Wang, et al. 2020. “Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity.” Cancer Immunology Research 8 (10): 1300–1310. https://doi.org/10.1158/2326-6066.cir-20-0304.
Harvard
Kotanides, H. et al. (2020) ‘Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity’, Cancer Immunology Research, 8(10), pp. 1300–1310. doi:10.1158/2326-6066.cir-20-0304.
IEEE
H. Kotanides et al., “Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity,” Cancer Immunology Research, vol. 8, no. 10, pp. 1300–1310, 2020, doi: 10.1158/2326-6066.cir-20-0304.
BibTeX
@article{kotanides2020bispecific,
title = {{Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity}},
author = {Kotanides, Helen and Li, Yiwen Helen and Malabunga, Maria and Carpenito, Carmine and Eastman, Scott W. and Shen, Yang and Wang, George and Inigo, Ivan V. and Surguladze, David and Pennello, Anthony L. and Persaud, Krishnadatt and Hindi, Sagit and Topper, Michael B. and Chen, Xinlei and Zhang, Yiwei and Bulaon, Danielle K. and Bailey, Tim and Lao, Yanbin and Han, Bing and Torgerson, Stacy and Chin, Darin and Sonyi, Andreas and Haidar, Jaafar N. Sleiman and Novosiadly, Ruslan D. and Moxham, Christopher M. and Plowman, Gregory D. and Ludwig, Dale L. and Kalos, Michael D.},
journal = {Cancer Immunology Research},
year = {2020},
volume = {8},
number = {10},
pages = {1300--1310},
doi = {10.1158/2326-6066.cir-20-0304},
url = {https://doi.org/10.1158/2326-6066.cir-20-0304}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 1 | |
| 2021 | 6 | |
| 2022 | 13 | |
| 2023 | 14 | |
| 2024 | 18 | |
| 2025 | 14 | |
| 2026 | 6 |
Its field-weighted citation impact is 3.13: it has been cited 3.13 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- bispecific antibodies
- PD-1
- PD-L1
- immune checkpoint blockade
- T cell activation
- antitumor immunity
- cancer immunotherapy
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Kotanides, H., Li, Y. H., Malabunga, M., Carpenito, C., Eastman, S. W., Shen, Y., Wang, G., Inigo, I. V., Surguladze, D., Pennello, A. L., Persaud, K., Hindi, S., Topper, M. B., Chen, X., Zhang, Y., Bulaon, D. K., Bailey, T., Lao, Y., Han, B., . . . Kalos, M. D. (2020). Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity. Cancer Immunology Research, 8(10), 1300–1310. https://doi.org/10.1158/2326-6066.cir-20-0304
How many times has this paper been cited?
72 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Helen Kotanides, Yiwen Helen Li, Maria Malabunga, Carmine Carpenito, Scott W. Eastman, Yang Shen, George Wang, Ivan V. Inigo, David Surguladze, Anthony L. Pennello, Krishnadatt Persaud, Sagit Hindi and 16 more.
What is the DOI of this paper?
10.1158/2326-6066.cir-20-0304, permanently at https://doi.org/10.1158/2326-6066.cir-20-0304. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.